AbbVie Inc. (ABBV) vs Advanced Micro Devices, Inc. (AMD)
See how AbbVie Inc. and Advanced Micro Devices, Inc. differ across market data and performance, so you can decide which asset best fits your strategy.
$256.42
NYSE
AbbVie Inc. is a pharmaceutical company with significant exposure to immunology through Humira, Skyrizi, and Rinvoq, and to oncology through Imbruvica and Venclexta. The company was spun off from Abbott in early 2013. Its 2020 acquisition of Allergan expanded its portfolio with additional products in aesthetics, including Botox. In 2024, AbbVie further strengthened its business through the acquisitions of Cerevel in neuroscience and ImmunoGen in oncology.
View Full Page$470.72
NasdaqGS
Advanced Micro Devices develops a broad range of digital semiconductors for end markets including PCs, gaming consoles, data centers with AI workloads, industrial systems, and automotive applications. The company has traditionally been strongest in central processing units and graphics processing units for PCs and data centers, while increasingly establishing itself as a notable competitor in AI GPUs and related hardware. AMD also provides the chips used in leading game consoles such as Sony PlayStation and Microsoft Xbox.
View Full PageKey Metrics Comparison
AbbVie Inc.ABBV
Market Cap$453.124B
Price$256.42
24h Change+0.37%
24h Volume$4.24M
Employees57,000
Shares Outstanding1,768,169,012
Advanced Micro Devices, Inc.AMD
Market Cap$768.439B
Price$470.72
24h Change+1.10%
24h Volume$12.25M
Employees31,000
Shares Outstanding1,630,338,779
Category Performance
Visual comparison across key categories. Ring fill represents relative strength or share between the two assets.
Market Share
Share of combined market cap
ABBV
37.1%AMD
62.9%Volume Share
Share of combined 24h volume
ABBV
25.7%AMD
74.3%24h Performance
Price change over last 24 hours
ABBV
0.37%AMD
1.10%Price Comparison
AbbVie Inc.
Advanced Micro Devices, Inc.